SUMO1 and Alzheimer disease: Based on various AD mouse models, several studies indicated changes in global levels of SUMO1 conjugates during amyloid pathology (Lee et al., 2014; Marcelli et al., 2017; McMillan, Brown, Henley & Cimarosti, 2011; Nistico et al., 2014).